Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?
Open Access
- 16 June 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
Abstract
In human type 1 diabetes and animal models of the disease, a diverse assortment of immune cells infiltrates the pancreatic islets. CD8(+) T cells are well represented within infiltrates and HLA multimer staining of pancreas sections provides clear evidence that islet epitope reactive T cells are present within autoimmune lesions. These bona fide effectors have been a key research focus because these cells represent an intellectually attractive culprit for beta cell destruction. However, T cell receptors are highly diverse in human insulitis. This suggests correspondingly broad antigen specificity, which includes a majority of T cells for which there is no evidence of islet-specific reactivity. The presence of "non-cognate" T cells in insulitis raises suspicion that their role could be beyond that of an innocent bystander. In this perspective, we consider the potential pathogenic contribution of non-islet-reactive T cells. Our intellectual framework will be that of a criminal investigation. Having arraigned islet-specific CD8(+) T cells for the murder of pancreatic beta cells, we then turn our attention to the non-target immune cells present in human insulitis and consider the possible regulatory, benign, or effector roles that they may play in disease. Considering available evidence, we overview the case that can be made that non-islet-reactive infiltrating T cells should be suspected as co-conspirators or accessories to the crime and suggest some possible routes forward for reaching a better understanding of their role in disease.This publication has 71 references indexed in Scilit:
- Molecular Anatomy and Number of Antigen Specific CD8 T Cells Required to Cause Type 1 DiabetesPLoS Pathogens, 2012
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsThe Journal of Experimental Medicine, 2012
- How Does Type 1 Diabetes Develop?Diabetes, 2011
- CD8 + T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa miceProceedings of the National Academy of Sciences of the United States of America, 2011
- Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular responseProceedings of the National Academy of Sciences of the United States of America, 2011
- Islet inflammation and CXCL10 in recent-onset type 1 diabetesClinical and Experimental Immunology, 2010
- T Cell Islet Accumulation in Type 1 Diabetes Is a Tightly Regulated, Cell-Autonomous EventImmunity, 2009
- Analysis of islet inflammation in human type 1 diabetesClinical and Experimental Immunology, 2008
- EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2The Journal of Experimental Medicine, 2008
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008